Hepatosplenic γδ T-cell lymphoma following seven malaria infections

Pathology International

Volumn 56, Issue 11, 2006, Pages 668-673

  Hassan, Rocío ^a,b   Franco, Sergio A L ^a   Stefanoff, Claudio Gustavo ^a   Romano, Sergio O ^a   Diamond, Hilda R ^a   Franco, Luiz G P ^a   Seuánez, Héctor N ^a   Zalcberg, Ilana R ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Hepatosplenic lymphoma; Malaria; TCR gene rearrangements

Indexed keywords

CD2 ANTIGEN; CD3 ANTIGEN; CD45RO ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; FAS LIGAND; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROCORTISONE; PERFORIN; PREDNISONE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; VINCRISTINE; DNA; LYMPHOCYTE ANTIGEN RECEPTOR;

ADULT; ARTICLE; B LYMPHOCYTE; BRAZIL; CANCER COMBINATION CHEMOTHERAPY; CANCER INFILTRATION; CARCINOGENESIS; CASE REPORT; CELL INTERACTION; CELL PROLIFERATION; CLINICAL FEATURE; CLONAL VARIATION; CONTROLLED STUDY; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FATALITY; GENE REARRANGEMENT; HEPATOSPLENIC T CELL LYMPHOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN TISSUE; IMMUNE DEFICIENCY; LIVER TUMOR; LYMPHOCYTIC INFILTRATION; MALARIA; MALE; NONHUMAN; PATHOGENESIS; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPLEEN TUMOR; SPLENOMEGALY; T CELL LYMPHOMA; T LYMPHOCYTE ACTIVATION; TUMOR CELL; BIOSYNTHESIS; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; MIDDLE AGED; PATHOLOGY;

DNA, NEOPLASM; FATAL OUTCOME; GENE REARRANGEMENT, DELTA-CHAIN T-CELL ANTIGEN RECEPTOR; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOPHENOTYPING; LIVER NEOPLASMS; LYMPHOMA, T-CELL; MALARIA; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SPLENIC NEOPLASMS;

EID: 33749984949     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2006.02027.x     Document Type: Article

References (31)

1. Persing DH, Prendergast FG. Infection, immunity and cancer. Arch Pathol Lab Med 1999; 123: 1015-22.
2. Carbone A, Gaidano G. Acquired immunodeficiency syndrome-related cancer: A study model for the mechanisms contributing to the genesis of cancer. Eur J Cancer 2001; 37: 1184-7.
3. Voulgarelis M, Moutsopoulos HM. Lymphoproliferation in autoimmunity and Sjogren's syndrome. Curr Rheumatol Rep 2003; 4: 317-23.
4. Kwiatkowski D. Cytokines and anti-disease immunity to malaria. Res Immunol 1991; 142: 702-11.
5. Kafuko GW, Burkitt DP. Burkitt's lymphoma and malaria. Int J Cancer 1970; 6: 1-9.
6. Rochford R, Cannon MJ, Moormann AM. Endemic Burkitt's lymphoma: A polymicrobial disease? Nature Rev Microbiol 2005; 2: 182-7.
7. Magrath I. The pathogenesis of Burkitt's lymphoma. Adv Cancer Res 1990; 55: 133-270.
8. Bates I, Bedu-Addo G, Rutherford T, Bevan D. Splenic lymphoma with villous lymphocyte in tropical West Africa. Lancet 1992; 340: 575-7.
9. Bates I, Bedu-Addo G. Chronic malaria and splenic lymphoma: Clues to understanding lymphoma evolution. Leukemia 1997; 11: 2162-7.
10. Weidmann E. Hepatosplenic T-cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia 2000; 14: 991-7.
11. De Wolf-Peeters C, Achten R. γδ T-cell lymphomas: A homogeneous entity? Histopathology 2000; 36: 294-305.
12. Khan WA, Yu L, Eisenbrey AB et al. Hepatosplenic gamma/delta T-cell lymphoma in immunocompromised patients. Report of two cases and review of literature. Am J Clin Pathol 2001; 116: 41-50.
13. Belhadj K, Reyes F, Farcet J-P et al. Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: Report on a series of 21 patients. Blood 2003; 102: 4261-9.
14. Bedu-Addo G, Bates I. Causes of massive tropical splenomegaly in Ghana. Lancet 2002; 360: 499-54.
15. Salhany KE, Feldman M, Kahn MJ et al. Hepatosplenic gammadelta T-cell lymphoma: Ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation. Hum Pathol 1997; 28: 674-85.
16. Stefanoff CG, Hassan R, Gonzalez AC et al. Laboratory strategies for efficient handling of paraffin-embedded tissues for molecular detection of clonality in Non-Hodgkin lymphomas. Diagn Mol Pathol 2003; 12: 79-87.
17. Taube T, Seeger K, Beyermann B et al. Multiplex PCR for simultaneous detection of the most frequent T cell receptor-delta gene rearrangements in childhood ALL. Leukemia 1997; 11: 1978-82.
18. Langerak AW, Szczepanski T, van der Burg M, Wolvers-Tettero IL, van Dongen JJ. Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations. Leukemia 1997; 11: 2192-9.
19. Zalis MG, Ferreira-da-Cruz MF, Balthazar-Guedes HC et al. Malaria diagnosis: Standardization of a polymerase chain reaction for the detection of Plasmodium falciparum parasites in low parasitized individuals. Parasitol Res 1996; 82: 612-16.
20. Harris N, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-92.
21. Van Dongen JJM, Wolvers-Tettero ILM. Analysis of immunoglobulin and T cell receptor genes. Possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders. Clin Chim Acta 1991; 198: 93-174.
22. Bates I, Bedu-Addo G, Bevan D, Rutherford T. Use of immunoglobulin gene rearrangements to show clonal lymphoproliferation in hyper-reactive malarial splenomegaly. Lancet 1991; 337: 505-7.
23. Carding SR, Egan PJ. γδ T cells: Functional plasticity and heterogeneity. Nat Rev Immunol 2002; 2: 336-45.
24. Tsuji M, Mombaert P, Lefrancois L, Nussenzweig RS, Zavala F, Tonegawa S. γδ T cells contribute to immunity against the liver stages of malaria in αβ T-cell-deficient mice. Proc Natl Acad Sci USA 1994; 91: 345-9.
25. Ramsey JM, Tello A, Contreras CO. Plasmodium falciparum and P. vivax gametocyte-specific exoantigens stimulate proliferation of TCR gamma/delta+ lymphocytes. J Parasitol 2002; 88: 59-68.
26. Hayday AC. γδ cells: A right time and a right place for a conserved third way of protection. Ann Rev Immunol 2000; 24: 3044-9.
27. Ferrarini M, Ferrero E, Dagna L, Poggi A, Zocchi MR. Human γδ T cells: A nonredundant system in the immune-surveillance against cancer. Trends Immunol 2002; 23: 14-18.
28. Hviid L, Akanmori BD, Loizon S et al. High frequency of circulating γδ T cells with dominance of the Vδ1 subset in a healthy population. Int Immunol 2000; 12: 797-805.
29. Hviid L, Kurtzhals JAL, Adabayeri V et al. Perturbation and proinflammatory type activation of Vδ1+ γδ T cells in African children with Plasmodium falciparum malaria. Infect Immun 2001; 69: 3190-96.
30. Zheng B, Marinova E, Han J, Tan T-H, Han S. γδ T cells provide help to B cells with altered clonotypes and are capable of inducing Ig gene hypermutation. J Immunol 2003; 171: 4979-83.
31. Li B, Bassiri H, Rossman MD et al. Involvement of the Fas/Fas-ligand pathway in activation-induced cell death of mycobacteria reactive human γδ T cells: A mechanism for the loss of γδ T cells in patients with pulmonary tuberculosis. J Immunol 1998; 161: 1558-67.